Hospices Civils de Lyon: Cystic Fibrosis trials

The registry lists 35 Cystic Fibrosis studies with Hospices Civils de Lyon as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 2 1No phase 34(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic FibrosisNot yet recruitingNCT07851831Not applicable
• Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric PopulationRecruitingNCT07303621
• CF Organization of Care in the Era of Highly Effective Modulator.RecruitingNCT06599892
• Physical Activity Profile and Sedentary Behaviour in Adults With Cystic FibrosisRecruitingNCT06507956
• Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) ModulatorsRecruitingNCT06370962
• Muscle Function and Physical Activity in the Modern Era of Cystic FibrosisRecruitingNCT06251622
• Renal Impact of KAFTRIO in Mucoviscidose PopulationRecruitingNCT06197490
• Peer-supporting for Teenagers With Cystic Fibrosis in the Transition of Care From Paediatric to Adult ServicesNot yet recruitingNCT05795673Not applicable
• Study of Satisfaction of Patients and Care Providers for an Alternate Follow-up With In-hospital Consults and Tele-consult for Patients With Cystic FibrosisRecruitingNCT05249322Not applicable
• Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care ProfessionalsRecruitingNCT03226795Not applicable
• Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTORActive, not recruitingNCT06184763
• Effectiveness of CFTR Modulators According to Co-therapyStatus unknownNCT05663255
• COVID-19 Antibody Responses in Cystic FibrosisCompletedNCT05614336Not applicable
• Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible MutationCompletedNCT05581056
• Training in Shared Decision-making of Cystic Fibrosis Centers Competences in the Treatment of CF Related Diabetes in Adult PatientsStatus unknownNCT04891159
• Iron Metabolism in Cystic FibrosisStatus unknownNCT04584489
• Diet, Physical Activity and Glucose Tolerance in Cystic Fibrosis. Exploratory Study.CompletedNCT04249466
• Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients With Cystic Fibrosis Aged 12 Years and OlderCompletedNCT04226118Not applicable
• Intimacy of Women With Cystic FibrosisCompletedNCT04225962
• Cystic Fibrosis Adherence StudyCompletedNCT04217889
• Gynecological Health Improvement of Adult Women With Cystic FibrosisCompletedNCT03892304
• Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)CompletedNCT03653377
• Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic FibrosisCompletedNCT03357913
• Pregnancies and Cystic FibrosisStatus unknownNCT03290144
• HPV Vaccination in Women With Cystic FibrosisCompletedNCT03265743
• Human Papillomavirus and Cervical Dysplasia in Women With Cystic FibrosisCompletedNCT03052556Not applicable
• Contraceptive Practices and Cervical Screening in Women With Cystic FibrosisCompletedNCT02847208
• Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.CompletedNCT02847156Not applicable
• Costs of Care and Adherence to Treatment for Cystic FibrosisCompletedNCT02832479
• Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two YearsCompletedNCT02803944
• Transition From Pediatric to Adult Cystic Fibrosis Care CenterStatus unknownNCT02790879
• Cystic Fibrosis Related Diabetes Screening.CompletedNCT02723968Not applicable
• Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)CompletedNCT02690857Phase 2
• Bone Microarchitecture in Young Cystic Fibrosis PatientsCompletedNCT01788267Not applicable
• Self Drainage in Pediatric Cystic Fibrosis PatientsCompletedNCT01509235Not applicable